Concert Pharmaceuticals, Inc. Interest Receivable, Current
Concert Pharmaceuticals, Inc. had Interest Receivable, Current of $208.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Notes › Nontrade Receivables, Current
us-gaap:InterestReceivableCurrent · last filed 2022-11-07
- 2022-09-30: Interest Receivable, Current $208.00K.
- 2022-06-30: Interest Receivable, Current $129.00K.
- 2022-03-31: Interest Receivable, Current $251.00K.
- 2021-12-31: Interest Receivable, Current $0.00.
| Period end | Interest Receivable, Current |
|---|---|
| 2022-09-30 | $208.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $129.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $251.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-07 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $27.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $145.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $314.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $244.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $428.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $260.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $291.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $436.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $382.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $556.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $514.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $511.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $580.00K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $628.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | $635.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $218.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $176.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | $164.00K 10-Q · filed 2017-11-09 |
| 2016-09-30 | $323.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $211.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $379.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $181.00K 10-Q · filed 2016-11-08 |
| 2015-09-30 | $231.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $281.00K 10-Q · filed 2015-08-05 |
| 2014-12-31 | $262.00K 10-Q · filed 2015-11-05 |